Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea | MicrobiomeTrials← Back to trialsNCT05874271
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-08-07Est. Completion: 2025-10-25
Enrollment target: 794 participants Locations- Napapar Health Centre, Kokopo, East New Britain Province, Papua New Guinea
- Wirui Clinic, Wewak, East Sepik Province, Papua New Guinea
- Mugil Health Centre, Madang, Madang Province, Papua New Guinea
- Baro Clinic, Vanimo, Sandaun Province, Papua New Guinea
Other microbiome trials you might be interested in
Malaria
Background:
Malaria is a disease caused by parasites transmitted to people by mosquitoes. Around the world, there were …
Bethesda, United StatesEst. completion Nov 26, 2027
Plasmodium Vivax MalariaMalaria
FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug a…
Iquitos, PeruEst. completion May 1, 2027